Home › Prostate Cancer › Utah
Prostate Cancer clinical trials in Utah
24 studies for Prostate Cancer are looking for participants at sites in Utah.
Cities in Utah
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Intermountain Medical Center, Murray
- McKay-Dee Hospital Center, Ogden
- LDS Hospital, Salt Lake City
- and 2 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 2, 2026 · NCT06931340A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University of Utah - Huntsman Cancer Institute, Salt Lake City
- START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06465069Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc
- Huntsman Cancer Institute and Hospital, Salt Lake City
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 30, 2026 · NCT05534646A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
- START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 25, 2026 · NCT07746713This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07028853Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Utah Intermountain Medical Center, Murray
RecruitingPhase 2/3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06780670First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- GSK Investigational Site, West Valley City
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 16, 2026 · NCT07332455Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Intermountain Health, Murray
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 11, 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- American Fork Hospital / Huntsman Intermountain Cancer Center, American Fork
- Sandra L Maxwell Cancer Center, Cedar City
- Farmington Health Center, Farmington
- and 9 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- Summit Urology, Murray
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 3, 2026 · NCT07723248AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Salt Lake City
RecruitingPhase 3
Ages 18 and older · Men · Updated Aug 26, 2026 · NCT07611110Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- START Mountain Region, West Valley City
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 24, 2026 · NCT07745361Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Intermountain Medical Center, Murray
RecruitingPhase 1
Ages 18 and older · Men · Updated Aug 21, 2026 · NCT04221542Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Huntsman Cancer Institute/University of Utah, Salt Lake City
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- Huntsman Cancer Institute, University of Utah, Salt Lake City
RecruitingPhase 1
Ages 18 and older · Men · Updated Jul 9, 2026 · NCT05413421Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
- START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT07517198Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
- Huntsman Cancer Institute/University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older · Men · Updated Jun 5, 2026 · NCT05168618Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression
- Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 3
Ages 18 and older · Men · Updated Jun 3, 2026 · NCT06112990Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer
- Huntsman Cancer Institute at University of Utah, Salt Lake City
Recruiting
Ages 18 and older · Men · Updated Apr 13, 2026 · NCT07093177A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- START Center for Cancer Care - Mountain Region, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06395519Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
- START, Mountain Region, West Valley City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT07145255SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Salt Lake City
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 11, 2025 · NCT03678025Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
- University of Utah Huntsman Cancer Institute, Salt Lake City
Recruiting
Ages 21 and older · Men · Updated Aug 1, 2025 · NCT07032584From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.